NEW YORK – Salt Lake City, Utah-based Predictive Technology on Friday announced a distribution agreement between its Predictive Laboratories subsidiary and Lakeland, Florida-based Wellgistics for distribution of its Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for use by labs and healthcare workers at the point-of-care in the US.
Wellgistics is a wholesale pharmaceutical distributor licensed in all 50 US states.
The single-use rapid test for qualitative detection of IgM and IgG antibodies associated with the SARS-CoV-2 virus provides results in 15 minutes, Predictive said. The firm further claims the test has shown a 92 percent sensitivity and 100 percent specificity, and helps determine whether a COVID-19 viral PCR test is needed.
The antibody test can be used to test people with symptoms of COVID-19, those who were exposed to someone infected with COVID-19, or those who want qualitative information about whether or not they have IgM or IgG antibodies, the firm said.
Bradley Robinson, CEO of Predictive Technology, said in a statement that the firm is "in production in advance of Wellgistics' purchase orders."